86 related articles for article (PubMed ID: 9168251)
1. Levuglandin E2-protein adducts in human plasma and vasculature.
Salomon RG; Subbanagounder G; O'Neil J; Kaur K; Smith MA; Hoff HF; Perry G; Monnier VM
Chem Res Toxicol; 1997 May; 10(5):536-45. PubMed ID: 9168251
[TBL] [Abstract][Full Text] [Related]
2. Oxidation of low-density lipoproteins produces levuglandin-protein adducts.
Salomon RG; Subbanagounder G; Singh U; O'Neil J; Hoff HF
Chem Res Toxicol; 1997 Jul; 10(7):750-9. PubMed ID: 9250408
[TBL] [Abstract][Full Text] [Related]
3. Formation and stability of pyrrole adducts in the reaction of levuglandin E2 with proteins.
DiFranco E; Subbanagounder G; Kim S; Murthi K; Taneda S; Monnier VM; Salomon RG
Chem Res Toxicol; 1995; 8(1):61-7. PubMed ID: 7703368
[TBL] [Abstract][Full Text] [Related]
4. Protein adducts of iso[4]levuglandin E2, a product of the isoprostane pathway, in oxidized low density lipoprotein.
Salomon RG; Sha W; Brame C; Kaur K; Subbanagounder G; O'Neil J; Hoff HF; Roberts LJ
J Biol Chem; 1999 Jul; 274(29):20271-80. PubMed ID: 10400646
[TBL] [Abstract][Full Text] [Related]
5. (Carboxyalkyl)pyrroles in human plasma and oxidized low-density lipoproteins.
Kaur K; Salomon RG; O'Neil J; Hoff HF
Chem Res Toxicol; 1997 Dec; 10(12):1387-96. PubMed ID: 9437530
[TBL] [Abstract][Full Text] [Related]
6. Formation of DNA-protein cross-links in mammalian cells by levuglandin E2.
Murthi KK; Friedman LR; Oleinick NL; Salomon RG
Biochemistry; 1993 Apr; 32(15):4090-7. PubMed ID: 8471616
[TBL] [Abstract][Full Text] [Related]
7. Levuglandin E2 crosslinks proteins.
Iyer RS; Ghosh S; Salomon RG
Prostaglandins; 1989 Apr; 37(4):471-80. PubMed ID: 2762557
[TBL] [Abstract][Full Text] [Related]
8. Macrophage recognition of LDL modified by levuglandin E2, an oxidation product of arachidonic acid.
Hoppe G; Subbanagounder G; O'Neil J; Salomon RG; Hoff HF
Biochim Biophys Acta; 1997 Jan; 1344(1):1-5. PubMed ID: 9022751
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the lysyl adducts formed from prostaglandin H2 via the levuglandin pathway.
Boutaud O; Brame CJ; Salomon RG; Roberts LJ; Oates JA
Biochemistry; 1999 Jul; 38(29):9389-96. PubMed ID: 10413514
[TBL] [Abstract][Full Text] [Related]
10. Electrophilic levuglandin E2-protein adducts bind glycine: a model for protein crosslinking.
Jirousek MR; Murthi KK; Salomon RG
Prostaglandins; 1990 Aug; 40(2):187-203. PubMed ID: 2217833
[TBL] [Abstract][Full Text] [Related]
11. Total Synthesis Confirms the Molecular Structure Proposed for Oxidized Levuglandin D
Cheng YS; Yu W; Xu Y; Salomon RG
J Nat Prod; 2017 Feb; 80(2):488-498. PubMed ID: 28195470
[TBL] [Abstract][Full Text] [Related]
12. Levuglandins and isolevuglandins: stealthy toxins of oxidative injury.
Salomon RG
Antioxid Redox Signal; 2005; 7(1-2):185-201. PubMed ID: 15650407
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the lysyl adducts of prostaglandin H-synthases that are derived from oxygenation of arachidonic acid.
Boutaud O; Brame CJ; Chaurand P; Li J; Rowlinson SW; Crews BC; Ji C; Marnett LJ; Caprioli RM; Roberts LJ; Oates JA
Biochemistry; 2001 Jun; 40(23):6948-55. PubMed ID: 11389610
[TBL] [Abstract][Full Text] [Related]
14. New developments in the isoprostane pathway: identification of novel highly reactive gamma-ketoaldehydes (isolevuglandins) and characterization of their protein adducts.
Roberts LJ; Salomon RG; Morrow JD; Brame CJ
FASEB J; 1999 Jul; 13(10):1157-68. PubMed ID: 10385607
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin endoperoxides 21. Covalent binding of levuglandin E2 with proteins.
Salomon RG; Jirousek MR; Ghosh S; Sharma RB
Prostaglandins; 1987 Nov; 34(5):643-56. PubMed ID: 3481092
[TBL] [Abstract][Full Text] [Related]
16. Distinguishing levuglandins produced through the cyclooxygenase and isoprostane pathways.
Salomon RG
Chem Phys Lipids; 2005 Mar; 134(1):1-20. PubMed ID: 15752459
[TBL] [Abstract][Full Text] [Related]
17. Antibody response to keyhole limpet hemocyanin (KLH) treatment in patients with superficial bladder carcinoma.
Jurincic-Winkler CD; von der Kammer H; Beuth J; Scheit KH; Klippel KF
Anticancer Res; 1996; 16(4A):2105-10. PubMed ID: 8712751
[TBL] [Abstract][Full Text] [Related]
18. Characterization of covalent adducts of nucleosides and DNA formed by reaction with levuglandin.
Carrier EJ; Amarnath V; Oates JA; Boutaud O
Biochemistry; 2009 Nov; 48(45):10775-81. PubMed ID: 19824699
[TBL] [Abstract][Full Text] [Related]
19. Brain tissue injury and blood-brain barrier opening induced by injection of LGE2 or PGE2.
Schmidley JW; Dadson J; Iyer RS; Salomon RG
Prostaglandins Leukot Essent Fatty Acids; 1992 Oct; 47(2):105-10. PubMed ID: 1461920
[TBL] [Abstract][Full Text] [Related]
20. Levuglandin E2 inhibits mitosis and microtubule assembly.
Murthi KK; Salomon RG; Sternlicht H
Prostaglandins; 1990 Jun; 39(6):611-22. PubMed ID: 2115185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
